The FDA has approved Northera on an accelerated basis to treat low blood pressure caused by neurological disorders.
Generic drug makers are planning on fighting the FDA's proposed regulations that would make these companies liable for any side effects suffered by consumers.
The FDA stated that medications made in India increase American consumers' risk of illnesses due to poor quality.
The FDA approved leukemia drug for chronic lymphocytic leukemia.
The FDA has asked Sprout Pharmaceuticals to perform more trials for its female sexual libido drug.
The FDA approved a pill-sized camera to be used by patients who cannot undergo a colonoscopy.
The FDA will launch a $115 million anti-tobacco campaign next week targeting at-risk youth.
The Natural Resources Defense Council reported that the FDA approved 18 "high risk" antibiotics for farm use.
The FDA plans on revising and updating the nutrition facts label.
A new study reported that the FDA's approval process varies greatly based on the drug.
The FDA has warned physicians against prescribing combination drugs containing acetaminophen.
The FDA reminds people to remember to stick to the instructions when taking over-the-counter laxatives.
The Food and Drug Administration has approved the drug dapagliflozin that helps in improving glycemic control in patients with Type 2 diabetes. The drug is the second of a new class of medications and will be marketed under the name Farxiga.
The U.S. FDA rejected Lemtrada, Sanofi's newest drug treatment for multiple sclerosis.
The vending machine industry are now mandated to provide calorie information, an overhaul that will cost the industry around $25.7 million initially.
The BioScience Talks podcast features discussions of topical issues related to the biological sciences. By altering the heritability of certain traits, gene drive technologies have the potential to spread desired genes through wild populations. In practice, this could lead to mosquito populations that, for example, bear traits making them resistant to the spread of malaria. Despite the huge potential for improving human well-being, concern exists that gene drives could fail in the wild or, perhaps more concerning, spread beyond their intended target populations.